½Å°æÁúȯ ½ÃÀåÁ¶»çº¸°í¼­

½Å°æÁúȯ(Neurodegenerative Disease) Ä«Å×°í¸®¿¡¼­´Â ½Å°æº¯¼º Áúȯ(´Ù¹ß¼º°æÈ­Áõ(MS), Ä¡¸Å, ¾ËÃ÷ÇÏÀ̸Ӻ´, °£Áú µî)À» Á¶»ç ´ë»óÀ¸·Î ÇÑ º¸°í¼­¸¦ ¼Ò°³ÇØ µå¸®°í ÀÖ½À´Ï´Ù. ÁßÃ߽Űæ°è ¾à¹° ÆÄÀÌÇÁ¶óÀÎ ¹× ¿¬±¸°³¹ß °ü·Ã °úÁ¦, ½ÃÀåÀÇ °¡´É¼º µî¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÑ º¸°í¼­µµ Çѵ¥ ¸ð¾Ò½À´Ï´Ù.

1 - 25 (Àüü: 578°Ç)
°æÁ÷ Ä¡·á ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, À¯Çüº°, ¾àÁ¦ Ŭ·¡½ºº°, ÃÖÁ¾»ç¿ëÀÚº°, ÀûÀÀÁõº°, Åõ¿© °æ·Îº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2025-2032³â)
Spasticity Treatment Market Size, Share, and Growth Analysis, By Type, By Drug Class, By End-user, By Indication, By Route Of Administration, By Region - Industry Forecast 2025-2032
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,300 £Ü 7,435,000 (ºÎ°¡¼¼ º°µµ)
½Å°æ ÅðÇ༺ Áúȯ ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, ¾àÁ¦ Ŭ·¡½ºº°, ÀûÀÀ Áúȯº°, Åõ¿© °æ·Îº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2025-2032³â)
Neurodegenerative Disease Market Size, Share, and Growth Analysis, By Drug Class, By Disease Indication, By Route of Administration, By End User, By Region - Industry Forecast 2025-2032
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,300 £Ü 7,435,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ È­Çпä¹ý À¯¹ß¼º ¸»ÃʽŰ溴Áõ Ä¡·á ½ÃÀå ±âȸ ¹× Àü·«(-2034³â)
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Opportunities And Strategies To 2034
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¸¸¼º ¿°Áõ¼º Å»¼öÃʼº ´Ù¹ß½Å°æ¿° ½ÃÀå : À¯Åë ä³Î, Åõ¿© °æ·Î, Áö¿ªº° ºÐ¼®°ú ¿¹Ãø(2025-2035³â)
Chronic Inflammatory Demyelinating Polyneuropathy Market - A Global and Regional Analysis: Focus on Distribution Channel, Route of Administration, and Region - Analysis and Forecast, 2025-2035
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,900 £Ü 6,874,000 (ºÎ°¡¼¼ º°µµ)
ÇÁ·¹°¡¹ß¸° ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® : Á¦Çüº°, ¿ëµµº°, ¾à¹° Á¾·ùº°, À¯Åë ä³Îº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2025-2032³â)
Pregabalin Market Size, Share, and Growth Analysis, By Forms (Oral Capsule, Oral Solution), By Application (Epilepsy, Neuropathic Pain), By Drug Class, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,300 £Ü 7,435,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÃµÀå°üÀý¿° Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Sacroiliitis Treatment Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¿ø¹ß¼º ÁøÇ༺ ´Ù¹ß¼º °æÈ­Áõ(PPMS) Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Primary Progressive Multiple Sclerosis (PPMS) Treatment Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Å°æÅðÇ༺ Áúȯ ½ÃÀå º¸°í¼­(2025³â)
Neurodegenerative Disease Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´Ù¹ß¼º °æÈ­Áõ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Multiple Sclerosis Treatment Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¿äõÃß ½Å°æ±Ù ÅëÁõ °ü¸® ½ÃÀå º¸°í¼­(2025³â)
Lumbosacral Radicular Pain Management Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¿äõÃß ½Å°æ±Ù ÅëÁõ ½ÃÀå º¸°í¼­(2025³â)
Lumbosacral Radicular Pain Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Å©¶óº£º´ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Krabbe Disease Treatment Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³ú¿° Ä¡·á ½ÃÀå ¿¹Ãø - ÁúȯÀ¯Çüº°, Åõ¿© °æ·Îº°, º´¿øÃ¼º°, À¯Åë ä³Îº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(-2032³â)
Encephalitis Treatment Market Forecasts to 2032 - Global Analysis By Disease Type (Primary encephalitis and Secondary encephalitis), Route of Administration, Causative Agent, Distribution Channel, End User and By Geography
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,150 £Ü 5,822,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °¡¹ÙÆæÆ¾ ½ÃÀå º¸°í¼­(2025³â)
Gabapentin Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Å°¾Æ¸® ±âÇü ½ÃÀå º¸°í¼­(2025³â)
Chiari Malformation Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³ú°æ»ö Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Cerebral Infarction Treatment Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¿îµ¿¿Ï¸¸ ½ÃÀå º¸°í¼­(2025³â)
Bradykinesia Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾Æ½ºÆÛ°Å ÁõÈıº ½ÃÀå º¸°í¼­(2025³â)
Asperger Syndrome Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Àü¹® º´¿ø(Á¤½Å°ú ¹× ¾à¹°³²¿ë°ú Á¦¿Ü) ½ÃÀå
Specialty (except Psychiatric and Substance Abuse) Hospitals
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,850 £Ü 8,206,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °æÈ­¿ä¹ý ½ÃÀå º¸°í¼­(2025³â)
Sclerotherapy Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ·¹Æ®ÁõÈıº ½ÃÀå º¸°í¼­(2025³â)
Rett Syndrome Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Æä³ë¹Ù¸£ºñÅ» ½ÃÀå º¸°í¼­(2025³â)
Phenobarbital Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Å°æ°¡¼Ò¼º ½ÃÀå º¸°í¼­(2025³â)
Neuroplasticity Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ·¹³ì½º °¡½ºÅä ÁõÈıº(LGS) Ä¡·áÁ¦ ½ÃÀå º¸°í¼­(2025³â)
Lennox-Gastaut Syndrome Drug Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÇåÆÃÅϺ´ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Huntington's Disease Treatment Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.